ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 8.76% of BTAI shares are held by financial institutions. PENNANT INVESTORS, LP is the top corporate investor, holding 83.9K shares valued at $236.60K. A 0.29% stake in BioXcel Therapeutics, Inc. is owned by the company. WELLS FARGO & COMPANY/MN owns 123.09K shares valued at $347.10K, which translates its holding of 0.42% of the stake in the company.
Among the BTAI insiders holding of 20.06% of the stake in company, BIOXCEL HOLDINGS, INC., 10 percent owner, holds the largest shares of 8.55M. BIOXCEL LLC, 10 percent owner, is the second largest BTAI insider with ownership of 8.55M shares. MUELLER PETER, director, stands third with possession of 168.32K shares of that stake.